We've found
31,654
archived clinical trials in
Cardiology
We've found
31,654
archived clinical trials in
Cardiology
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Safety and Hemostatic Efficacy of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated (FS VH S/D) Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Updated: 4/4/2017
Evaluation of the Topical Hemostatic Efficacy and Safety of Fibrin Sealant Vapor Heated, Solvent/Detergent Treated Compared With Currently Licensed TISSEEL VH Fibrin Sealant in Subjects Undergoing Cardiac Surgery
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study
Updated: 4/4/2017
The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study
Status: Enrolling
Updated: 4/4/2017
The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study
Updated: 4/4/2017
The Prevention of Myocardial Enlargement and Dilatation Post Myocardial Infarction Study
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers
Updated: 4/4/2017
The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers
Status: Enrolling
Updated: 4/4/2017
The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers
Updated: 4/4/2017
The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers
Updated: 4/4/2017
The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers
Status: Enrolling
Updated: 4/4/2017
The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers
Updated: 4/4/2017
The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers
Updated: 4/4/2017
The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers
Status: Enrolling
Updated: 4/4/2017
The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers
Updated: 4/4/2017
The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)
Updated: 4/4/2017
A Phase I/II Randomized, Double-Masked, Multicenter Clinical Trial Designed to Evaluate the Safety and Exploratory Efficacy of SF0166 Topical Ophthalmic Solution in the Treatment of Diabetic Macular Edema (DME)
Status: Enrolling
Updated: 4/4/2017
Click here to add this to my saved trials
Spironolactone in Adult Congenital Heart Disease
Updated: 4/5/2017
Heart Failure in Congenital Heart Disease: the Role of Myocardial Fibrosis. Treatment Sub-Study: Spironolactone vs. Placebo
Status: Enrolling
Updated: 4/5/2017
Spironolactone in Adult Congenital Heart Disease
Updated: 4/5/2017
Heart Failure in Congenital Heart Disease: the Role of Myocardial Fibrosis. Treatment Sub-Study: Spironolactone vs. Placebo
Status: Enrolling
Updated: 4/5/2017
Click here to add this to my saved trials
The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)
Updated: 4/5/2017
The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)
Status: Enrolling
Updated: 4/5/2017
The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)
Updated: 4/5/2017
The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)
Status: Enrolling
Updated: 4/5/2017
Click here to add this to my saved trials
The Roles of Tissue Factor in Malignant Gliomas
Updated: 4/5/2017
The Roles of Tissue Factor in Malignant Gliomas
Status: Enrolling
Updated: 4/5/2017
The Roles of Tissue Factor in Malignant Gliomas
Updated: 4/5/2017
The Roles of Tissue Factor in Malignant Gliomas
Status: Enrolling
Updated: 4/5/2017
Click here to add this to my saved trials
The Roles of Tissue Factor in Malignant Gliomas
Updated: 4/5/2017
The Roles of Tissue Factor in Malignant Gliomas
Status: Enrolling
Updated: 4/5/2017
The Roles of Tissue Factor in Malignant Gliomas
Updated: 4/5/2017
The Roles of Tissue Factor in Malignant Gliomas
Status: Enrolling
Updated: 4/5/2017
Click here to add this to my saved trials
The Roles of Tissue Factor in Malignant Gliomas
Updated: 4/5/2017
The Roles of Tissue Factor in Malignant Gliomas
Status: Enrolling
Updated: 4/5/2017
The Roles of Tissue Factor in Malignant Gliomas
Updated: 4/5/2017
The Roles of Tissue Factor in Malignant Gliomas
Status: Enrolling
Updated: 4/5/2017
Click here to add this to my saved trials
Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
Updated: 4/6/2017
Multiple-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
Status: Enrolling
Updated: 4/6/2017
Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
Updated: 4/6/2017
Multiple-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
Status: Enrolling
Updated: 4/6/2017
Click here to add this to my saved trials
Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
Updated: 4/6/2017
Multiple-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
Status: Enrolling
Updated: 4/6/2017
Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
Updated: 4/6/2017
Multiple-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
Status: Enrolling
Updated: 4/6/2017
Click here to add this to my saved trials
Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
Updated: 4/6/2017
Multiple-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
Status: Enrolling
Updated: 4/6/2017
Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
Updated: 4/6/2017
Multiple-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
Status: Enrolling
Updated: 4/6/2017
Click here to add this to my saved trials
Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
Updated: 4/6/2017
Multiple-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
Status: Enrolling
Updated: 4/6/2017
Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
Updated: 4/6/2017
Multiple-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
Status: Enrolling
Updated: 4/6/2017
Click here to add this to my saved trials
Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
Updated: 4/6/2017
Multiple-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
Status: Enrolling
Updated: 4/6/2017
Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
Updated: 4/6/2017
Multiple-Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter
Status: Enrolling
Updated: 4/6/2017
Click here to add this to my saved trials
Model for Heart Failure ExAcerbation Reduction Trial
Updated: 4/10/2017
Model for Heart Failure ExAcerbation Reduction Trial - "Model HEART"
Status: Enrolling
Updated: 4/10/2017
Model for Heart Failure ExAcerbation Reduction Trial
Updated: 4/10/2017
Model for Heart Failure ExAcerbation Reduction Trial - "Model HEART"
Status: Enrolling
Updated: 4/10/2017
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Updated: 4/12/2017
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Updated: 4/12/2017
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Updated: 4/12/2017
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Updated: 4/12/2017
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Updated: 4/12/2017
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Updated: 4/12/2017
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Updated: 4/12/2017
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Updated: 4/12/2017
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Updated: 4/12/2017
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Updated: 4/12/2017
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Updated: 4/12/2017
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Updated: 4/12/2017
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Click here to add this to my saved trials
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Updated: 4/12/2017
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Neuroprotection in Patients Undergoing Aortic Valve Replacement
Updated: 4/12/2017
Neuroprotection In Patients Undergoing Aortic Valve Replacement
Status: Enrolling
Updated: 4/12/2017
Click here to add this to my saved trials